NMPA Approval

Tizanidine Hydrochloride Orally Disintegrating Tablets

Approval Number

国药准字H20140147

Registration Date

February 6, 2024

Drug Information

Generic Name

盐酸替扎尼定口腔崩解片

Brand Name

普特彼

Dosage Form

片剂

Strength

4mg(按C₉H₈ClN₅S计)

Drug Type

化学药品

Registration Date

February 6, 2024

Company Address

四川省泸州国家高新区医药产业园

Company Address

四川省泸州国家高新区医药产业园曲河西路8号

Empowering clinical research with data-driven insights and AI-powered tools.

盐酸替扎尼定口腔崩解片 - NMPA 批准文号 | MedPath